Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the effectiveness of intralesional (IL)
PV-10 for locoregional treatment of metastatic melanoma. This study will also include
assessment of response in untreated bystander lesions following intralesional injection of
PV-10 into targeted lesions. Additional objectives are to determine the safety profile of
PV-10 following intralesional injection, and assess the pharmacokinetic profile of PV-10 in
the bloodstream following intralesional injection.